Synthetic Psychedelic
First synthesised in 1912 by Anton Kollisch. Known to induce euphoria and increased sociability
Mechanism of action
Increased reputable and release of serotonin and norepinephrine. Increased oxytocin release may also play a role
Indications
PTSD, Autism, Obesity, Narcolepsy and ADHD
Ongoing research conducted by
Awakn life sciences, Atai, MAPS, Beckley Psytech and Tactogen